GSK successful in Phase III inflammation trial
This is a discussion on GSK successful in Phase III inflammation trial within the Biotechnology News forum, part of the Industry News and Updates category; GlaxoSmithKline says that a late-stage trial of Bosatria demonstrated its ability to effectively control a rare inflammatory ailment. Researchers ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
03-19-2008, 08:08 AM
|
|||
|
|||
GSK successful in Phase III inflammation trial
GlaxoSmithKline says that a late-stage trial of Bosatria demonstrated its ability to effectively control a rare inflammatory ailment. Researchers were testing the drug's ability to control symptoms Read more...
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Pfizer halts Phase III cancer trial on poor results | industry_news | Biotechnology News | 0 | 04-02-2008 01:39 PM |
| Rare disease puts Phase III vax trial on hold | industry_news | Biotechnology News | 0 | 03-19-2008 08:08 AM |
| Wyeth, Progenics drug flunks Phase III trial | industry_news | Biotechnology News | 0 | 03-19-2008 08:08 AM |
© 2008 DrugManagementForum™ powered by |
 |